ALEJANDRO GONZALEZ

Mr. ALEJANDRO GONZALEZ

ITESM
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
AGALEJANDRO GONZALEZ
ALEJANDRO GONZALEZ
JHJesús Hernández-Pérez
Jesús Hernández-Pérez
Hafiz M. N. IqbalHafiz M. N. Iqbal
Hafiz M. N. Iqbal
Marco Rito-PalomaresMarco Rito-Palomares
Marco Rito-Palomares
JBJorge Benavides
Jorge Benavides
Vaccines are considered one of the most important bioproducts in medicine. Since the development of the smallpox vaccine in 1796, several types of vaccines for many diseases have been created. However, some vaccines have shown limitations as high cost and low immune responses. In that regard, bacteriophages have been proposed as an attractive alternative for the development of more cost-effective vaccines. Phage-displayed vaccines consists in the expression of antigens on the phage surface. This approach takes advantage of inherent properties of these particles such as their adjuvant capacity, economic production and high stability, among others. To date, three types of phage-based vaccines have been developed: phage-displayed, phage DNA and hybrid phage-DNA vaccines. Typically, phage display technology has been used for the identification of new and protective epitopes, mimotopes and antigens. In this context, phage particles represent a versatile, effective and promising alternative for the development of more effective vaccine delivery systems which should be highly exploited in the future. This review describes current advances in the development of bacteriophage-based vaccines, with special attention to vaccine delivery strategies. Moreover, the immunological aspects of phage-based vaccines, as well as the applications of phage display for vaccine development, are explored. Finally, important challenges and the future of phage-bases vaccines are discussed.

4 August 2017 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Closed access
PDF file
AGALEJANDRO GONZALEZ
ALEJANDRO GONZALEZ
FRFederico Ruiz‐Ruiz
Federico Ruiz‐Ruiz
JBJorge Benavides
Jorge Benavides
RWRichard C Willson
Richard C Willson
Marco Rito-PalomaresMarco Rito-Palomares
Marco Rito-Palomares

6 July 2020 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Closed access
PDF file
MTMario Torres‐Acosta
Mario Torres‐Acosta
AGALEJANDRO GONZALEZ
ALEJANDRO GONZALEZ
FRFederico Ruiz‐Ruiz
Federico Ruiz‐Ruiz
MRMarco Rito‐Palomares
Marco Rito‐Palomares
JBJorge Benavides
Jorge Benavides

8 June 2018 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
AGALEJANDRO GONZALEZ
ALEJANDRO GONZALEZ
FRFederico Ruiz‐Ruiz
Federico Ruiz‐Ruiz
JBJorge Benavides
Jorge Benavides
Marco Rito-PalomaresMarco Rito-Palomares
Marco Rito-Palomares